Monday, July 25, 2016

BRIEF-Merck designated breakthrough therapy by FDA and gets prime status from EMA for ebola vaccine

* Merck is responsible for research, development,

manufacturing, and regulatory efforts in support of v920

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)